Topical and systemic retinoid therapy for cutaneous T-cell lymphoma
Authors:
- 1 December 2003
- journal article
- review article
- Published by Elsevier in Hematology/Oncology Clinics of North America
- Vol. 17 (6) , 1405-1419
Abstract
No abstract availableKeywords
This publication has 66 references indexed in Scilit:
- RESEARCH REPORT Bexarotene capsules and gel for previously treated patients with cutaneous T‐cell lymphoma: Results of the Australian patients treated on phase II trialsAustralasian Journal of Dermatology, 2001
- Twenty-year trends in the reported incidence of mycosis fungoides and associated mortality.American Journal of Public Health, 1999
- Current Use and Future Potential Role of Retinoids in DermatologyDrugs, 1997
- Combined modality therapy for cutaneous T-cell lymphomaJournal of the American Academy of Dermatology, 1996
- Combined treatment with oral etretinate and electron beam therapy in patients with cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome)Journal of the American Academy of Dermatology, 1992
- Antiproliferative activity of retinoids, interferon α and their combination in five human transformed cell linesCancer Letters, 1991
- Treatment of cutaneous T cell lymphoma with a combination of low-dose interferon alfa-2b and retinoidsJournal of the American Academy of Dermatology, 1991
- Potentiation of retinoid-induced differentiation of HL-60 and U937 cell lines by cytokinesEuropean Journal of Cancer and Clinical Oncology, 1991
- Retinoids in Cutaneous T Cell LymphomasDermatology, 1987
- Treatment of cutaneous T-cell lymphoma with the arotinoid Ro 13-6298Journal of the American Academy of Dermatology, 1987